AMR is a major global health challenge - for humans, animals, plants, and the environment.

Our research in this field spans a broad spectrum. From improving existing antibiotics and optimising their use, to developing new antimicrobial agents and pursuing innovative diagnostic solutions, we’re combatting antimicrobial resistance for the benefit of the world today and for future generations.

Explore our work and find out how you can collaborate with our leading academics to prevent antimicrobial resistance together.

Therapeutics innovation Scientist pipetting sample into a multiwell plate in lab stock photo

Therapeutics innovation research frontier

Combining world-class pharmacology and chemistry expertise to transform global health and medicine.

Streak plate for Bacteria culture or identify Bacteria research in labmicrology.

The David Price Evans Global Health and Infectious Diseases Research Group

Focusing on the management of infectious diseases around the world.
Close up on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory

Open Innovation Hub for Antimicrobial Surfaces

Designing a new generation of intelligent surfaces and materials to tackle antimicrobial resistance.
A photograph of various medicines

THE Connect: saving lives with antimicrobial optimisation

Professor Alison Holmes, Professor William Hope, and Dr Ishwar Singh discuss the global challenge posed by antimicrobial resistance.
A stock image of Leuconostoc Colony up close

Combatting AMR through research commercialisation

Spin-out company PhenUTest Diagnostics is providing innovative point-of-care testing for urinary tract infections.
Designing antimicrobial biomaterials Bacteria Germ Pathogen Illustration

Designing antimicrobial biomaterials

Pioneering breakthrough approaches to counter AMR by developing alternative antimicrobials to antibiotics and innovative delivery platforms.

University leads thinking on new information systems to tackle AMR at a national level

Our researchers have worked with partners to set out a vision for protecting the UK against antimicrobial resistance.

Launching the Fleming Fund Fellowship Scheme in Nigeria

Dr Steve Aston, Senior Clinical Lecturer in Infectious Diseases, recently travelled with colleagues to Nigeria for the orientation workshop for the Phase II Fellows.

A global commitment to reduce deaths linked to AMR by 10% before 2030

Professor Alison Holmes, David Price Evans Chair in Global Health and Infectious Diseases, recently joined the United Nations General Assembly high-level meeting.